With the use of a newly developed solid-phase radioimmunoassay method, the major antigenic determinants of human small-intestinal goblet-cell mucin were investigated and related to the overall tertiary structure of the mucin. Preliminary hapten inhibition studies with various oligosaccharides of known sequence and structure suggested that the determinants did not reside in carbohydrate. Exhaustive thiol reduction, however, almost abolished antigenicity, caused breakdown of the mucin into small heterogeneous glycopeptides, and liberated a 'link' peptide of M 118000.
was destroyed much more slowly with time (70% by 24h, 100% by 72h). Despite the loss of antigenicity, 72h-Pronase-digested glycopeptides retained all of the carbohydrate of the native mucin. Therefore the antibody to human small-intestinal mucin appears to recognize a 'naked' (non-glycosylated and Pronase-susceptible) peptide region(s) of mucin glycopeptides. For full antigenicity, however, disulphide bonds are required to stabilize a specific three-dimensional configuration of the 'naked' region.
Human small-intestinal mucin is synthesized in and secreted by goblet cells of the small intestine as a large-Mr glycoprotein complex consisting of oligosaccharide side chains (>70% by weight) attached to a peptide core. The carbohydrate is distinguished by its lack of mannose and the presence of O-glycosidic linkages between Nacetylgalactosamine on the oligosaccharide chains and threonine (or serine) residues in the peptide. The peptide is distinguished by the prominence of serine, threonine and proline residues (Jabbal et al., 1976; Wesley et al., 1983) .
There is a growing recognition that mucins are relevant to the pathophysiology of intestinal diseases such as chronic inflammatory bowel disease (Clamp et al., 1981; Ehsanullah et al., 1982a,b) , secretory diarrhoeas of bacterial and parasitic origin (Sherr et al., 1979; Miller & Yawa, 1979; Forstner et al., 1981) , gastric and duodenal ulceration (Younan et al., 1982) , cholelithiasis (Lee, 1981 ; Lee et al., 1981) , colonic adenocarcinoAbbreviation used: SDS, sodium dodecyl sulphate. ma (Gold & Miller, 1978; Filipe & Fenger, 1979; Boland et al., 1982a,b) and mucus obstruction in cystic fibrosis (di Sant'Agnese et al., 1981; Wesley et al., 1983) .
In previous studies we have shown that an antibody developed in rabbits against purified goblet-cell mucin of human small intestine can be localized by immunofluorescence specifically to goblet cells. By using a double-antibody radioimmunoassay method we further demonstrated that the antibody was highly specific to human small-intestinal mucin, giving weak or no crossreactivity with mucins of other organs and species, and no reaction with brush-border membranes, connective tissues or human serum .
The specificity of the antibody indicated that human mucin contains unique antigenic determinants not shared by other mucins of similar general composition and size, such as rat (Fahim et at., 1983) or pig smallintestinal mucins. With the use of a competitive solid-phase radioimmunoassay method, we underVol. 217 took the present study to determine whether these unique determinants reside in the three-dimensional configuration of the mucin molecule or its carbohydrate or peptide moieties. Our findings suggest that antigenicity resides in 'naked' peptide segments within the core of large mucin glycopeptide components.
Methods

Preparation of human mucin
Human small intestine was obtained within 8h post mortem from patients with cystic fibrosis or others having no known intestinal disease. Gobletcell mucin was isolated and purified by the method of Wesley et al. (1983) . In both cases the final mucin samples were highly purified, as judged by SDS/polyacrylamide-gel electrophoresis and the absence of mannose and uronic acid. Protein constituted approx. 10-16% by weight, as shown earlier by Jabbal et al. (1976) .
Radioimmunoassay of mucin
The antibody to mucin was a 40%-(w/v)-(NH4)2SO4 fraction of immune rabbit sera described and used earlier in a double-antibody radioimmunoassay .
A more convenient solid-phase radioimmunoassay method was used in the present study, and the optimum procedure is outlined in Table 1 . At each stage of the procedure, conditions were optimized by investigating variables of time (0-24h), temperature (4-370C) and relative concentrations of antigen and antibody. All solutions were made in phosphate-buffered saline (0.1 M-NaCl/ 0.lM-Na2HPO4/NaH2PO4 buffer, pH 7.4) containing 0.02% NaN3. Radioactivities in wells were counted in a Beckman 8000 y-radiation counter. Chemical analyses Carbohydrate was analysed by g.l.c. of trifluoroacetate derivatives of mucin hydrolysates as described earlier (Wesley et al., 1983) . Protein was analysed by the method of Lowry et al. (1951) , with bovine serum albumin as standard, and by amino acid analysis of samples hydrolysed for 24h in vacuo at 110°C in 5.5M-HCI with the use of a Durrum D-500 automatic amino acid analyser.
Preparative gel electrophoresis
Mucin samples containing 1mg of protein were reduced at 100°C for 5min in 0.2M-2-mercaptoethanol, in the presence of 1% SDS, in 0.1 M-Tris/ borate buffer, pH 8.6. Electrophoresis was carried out in 7.5%-polyacrylamide slab gels for 17h at 7mA/gel in 0.1% SDS, with 0.2M-Tris/borate, pH 8.6, as the electrode buffer. The resulting 118000 Mr band was removed by electro-elution and subjected to dialysis and ion-pair extraction (Henderson et al., 1979) to remove mercaptoethanol, buffer salts and detergent.
Results
Radioimmunoassay of human mucin
The optimum conditions of immunoassay are provided in Table 1 (Fig. 1) . Subsequent standard curves (Fig. 2) led us to choose an antibody dilution of 1:6000 (arrow) for routine use. Under these conditions, the Bo value was 75% of maximal binding, the Bso was 32ng of mucin (protein), the range of antigen detected was 6-lOOng of mucin (protein), and the inter-assay variation was less than 10% for each point. Carbohydrate cross-reactivity
The following carbohydrates were used as haptens in the radioimmunoassay and gave no reaction with the mucin antibody: (a) monosaccharides (3 nmol-25 ymol/assay): fucose, N-acetylneuraminic acid, galactose, glucose, mannose, N-acetylglucosamine, N-acetylgalactosamine, all sugars together; (b) conjugated monosaccharides (50-400nmol/assay): f-pNO2Ph-Gal, /3-pNO2Ph-GlcNAc, a-pNO2PhGlcNAc, fi-p-NO2Ph-GalNAc, a-Ph-GalNAc; (c) disaccharides (25-200nmol/ assay): Gal-f,l-3-GalNAc, Gal-fil-3-(a-oNO2Ph-) GalNAc, Gal-fil-3-(fi-pNO2Ph-)GalNAc, Gal-,Bl-3-GlnNAc, Gal-fil-3-(o-Me-)GlcNAc, Gal-11-3-(3-pNO2Ph -)GlcNAc, GlcNAc -(1 -6 -(a-oNO2Ph-)GalNAc, Fuc-#l-3-(a-PhCH2-)GalNAc; (d) trisaccharides (25-200nmol) : Gal-fl1-3-(GlcNAc-fil-6)(o-PhCH2-)GalNAc, Fuc-al-2-Gal-,Bl-3-GalNAc-ol, Fuc-al-2-Gal-fi1-3-(a-Ph-)-GalNAc; (e) oligosaccharides from rat colonic mucin (2.5-lOug/assay): NeuAc-a2--6-GalNAcol, Gal-13l-4-GlcNAc-p1-3-GalNAc-ol, GlcNAc-P1-3-(NeuAc-a2-6-)GalNAc-ol, Gal-/fl-3-GlcNAc-,Bl-3-(NeuAc-a2-6-)GalNAc-ol.
Since all of the sugar sequences and linkages present in the above structures would be expected to occur in human intestinal mucin, their lack of reactivity, even at high concentrations, suggests that they do not contribute to antigenic determinants in the mucin. Amino acid cross-reactivity
Hapten inhibition studies similar to those used to assess carbohydrate cross-reactivity were also performed with individual amino acids. They were pooled into groups as follows, and gave no reaction: (a) serine, threonine, proline (0.45-7.2 ymol/assay); (b) . To achieve more complete reduction in the present study, mucin samples were reduced at pH 8.6 in 0.2M-2-mercaptoethanol with or without 1% SDS for 5min at 100°C. (Reduction for 48 or 72h at 4°C gave similar results.) Three mucin samples all showed a significant decrease in size after reduction (Fig. 3) , with about 80% of the periodate/Schiff-reactive material forming a broad peak in the partially included volume, suggesting a heterogeneous distribution of glycoproteins of various sizes. There was no significant change in the overall carbohydrate profile of reduced mucin (results not shown), but a major decrease occurred in the slope and B50 of the radioimmunoassay (Table 2) . Some loss in the number of antigenic determinants (as reflected by increased B50 values) was due to boiling (or boiling with SDS), but the major loss of antigen-antibody affinity (i.e. decreased slopes) was clearly a result of reduction. Thus intra-or inter-molecular disulphide bonds in the peptide are very important for the antigenicity of human mucin.
Mucin samples were examined by silver staining in 7.5%-polyacrylamide gels containing 0.1% SDS (Fig. 4a) . As expected, untreated or native mucin barely penetrated the gel, and no other bands were detected. After reduction, however, a strong band of higher mobility appeared and, by comparison with protein standards, was assigned an M, value of 118000. This finding was similar to that observed for rat intestinal mucin (Fahim et al., 1983) , in which a non-glycosylated peptide of apparent Mr 118 000 appeared on gels after reduction. It is tentatively assumed therefore that the band from human mucin is a similar 'link' peptide. The gels were subjected to electrophoretic transfer (Western 'blot') on to nitrocellulose sheets and treated sequentially with mucin antibody (1: 400 dilution) and 125I-labelled protein A. Autoradiography (Fig. 4b ) indicated that the 'link' peptide was not significantly antigenic and that, after reduction, the large-Mr components carrying residual antigenicity penetrated the gel to a greater extent than in the case of unreduced mucin. This finding is in keeping with the Sepharose 2B column data (Fig. 3) showing similar and more heterogeneous mucin components after reduction.
In separate experiments, the 1 18000-Mr band was electro-eluted from preparative 7.5%-polyacrylamide slab gels, and gave no reactivity in the radioimmunoassay (slope < 0. 15), thus confirming the relative inactivity of this pept-ide as an antigen.
Pronase digestion of reduced mucin
To discover the nature of the residual antigen seen after a Western 'blot' of reduced mucin (Fig.  4b) , a sample of native mucin was first reduced in the presence of 1% (w/v) SDS, and the glycoprotein fraction was isolated in the excluded volume of Sepharose 4B columns. A portion of this peak was kept as a control, and the remainder was digested with Pronase for 72h at 37°C. A subsequent Western 'blot' step ( Fig. 4c) showed that the radioactivity present in the control reduced mucin sample disappeared after Pronase treatment. Thus the residual antigenicity must have been contained within (or was strongly dependent upon) nonglycosylated ('naked') regions of the peptide backbone of the large-Mr glycopeptides of the mucin.
Pronase digestion of native mucin
In an effort to discover whether the major antigenic determinants of native mucin (i.e. before reduction) could also be attributed to peptide, timed digestions with Pronase were carried out and the products tested for alterations in structure and antigenicity. (-) and after (+) Pronase treatment were subjected to Western'blot'. Note the loss of antigenicity after the Pronase treatment. Elution volume (ml) Fig. 5 . Sepharose 2B chromatography ofPronase-digested human small-intestinal mucin (a) Control mucin (2mg dry wt.) (El) and 24h-Pronase-digested mucin (3mg dry wt.) (U) were chromatographed on Sepharose 2B
(150cm x 1.5cm), eluted with 0.2M-NaCl containing 0.02% NaN3. (b) 72h-Pronase-digested mucin (4mg) was chromatographed similarly on a longer Sepharose 2B column (180cm x 1.5 cm) to show multiple degradation species. Glycoprotein was measured in all cases by the periodate/Schiff assay as described in the Methods section. V, and VO are the included volume and the totally excluded volume respectively. , and the present experiments failed to elicit a hapten response to mono-, di-, tri-and oligo-saccharides typical of mucin structures.
After exhaustive reduction of disulphide bonds, several structural changes took place in the mucin, some of which were no doubt responsible for the marked decrease in the affinity of the mucin for its antibody. The major change was a decrease in size, indicating that the mucin macromolecule(s) had depolymerized (or disaggregated) into a broad spectrum of heterogeneous glycoprotein (or glycopeptide) components. SDS/polyacrylamide-gel electrophoresis demonstrated the release of a 118000-Mr peptide, assumed by analogy with rat (Fahim et al., 1983) and pig mucins to represent a disulphide-bonded 'link' peptide in the native mucin. When examined by Western 'blot' or radioimmunoassay, this peptide was not significantly antigenic. The large glycopeptides, however, retained some antigenicity, and the latter was abolished by digestion with Pronase. Thus non-glycosylated or 'naked' peptide regions in the peptide core of the large glycopeptides appear to play an important part in creating antigenic sites on the mucin.
Greater insight into the importance of peptide was provided by timed Pronase digestion of native (or intact) mucin preparations. By 8 h of digestion considerable degradation of the mucin occurred, and the 'link' peptide could no longer be detected before or after reduction. At the same time, however, most of the mucin preparations retained considerable numbers of antigenic determinants (40-75% by radioimmunoassay) and a normal affinity of those determinants for the antibody. Only with prolonged digestion and extensive mucin degradation were the antigenic sites abolished. Yet only 23-30% of the original mucin peptide (by weight) was lost after 72h. We conclude therefore that the major antigen is peptide in nature, and, because it is relatively resistant to Pronase, it is probably located in a region close to the attachment of oligosaccharide chains (Fig. 7) . In addition, disulphide bonds (intramolecular) probably stabilize a specific tertiary configuration of the antigenic 'naked' peptide at the ends (Fig. 7a ) or in the middle (Fig. 7b ) of glycopeptide components.
In summary, the antibody to human mucin seems to recognize a specific segment of peptide that is needed for attachment of glycopeptide(s) to 'link' peptide, and which is stabilized by disulphide bonds. Future applications of interest may thus include immunological evaluation of proteolytically degraded or altered mucin produced in various states of health and disease. 
